References
- Pratt W B, Feketey R. The antimetabolites. The Antimicrobial Drugs. Oxford University Press, New York 1986; 229–251
- Kucers A, Bennett N. Sulfonamides. The Use of Antibiotics, 4th ed. JB Lippincott, Philadelphia 1987; 1075–1117
- Then R L. Mechanisms of resistance to trimethoprim, the sulfonamides, and trimethoprim-sulfamethoxazole. Clin Infect Dis 1982; 4: 261–269
- Zinner S H, Mayer K H. Sulfonamides and trimethoprim. Principles and Practice of Infectious Diseases, 4th ed, GL Mandell, JE Bennett, R Dolin. Churchill-Livingstone, New York 1995; 354–364
- Reeves D. Sulphonamides and trimethooprim. Lancet 1982; 2: 370–373
- Lerner P I. Nocardia species. Principles and Practice of Infectious Diseases, 4th ed, GL Mandell, JE Bennett, R Doh. Churchill-Livingstone, New York 1995; 2273–2280
- Beamon M H, McCabe R E, Wong S Y, Remington J E. Tox-oplusma gondii. Principles and Practice of Infectious Diseases, 4th ed, GL Mandell, JE Bennett, R Doh. Cburchill-Livingstone, New York 1995; 2455–2475
- Abramowicz M. Drugs for parasitic infections. The Medical Letter Handbook of Antimicrobial Therapy. New Rochelle 1998; 101–121
- Sahai J, Heimberger T, Collins K. Sufadiazine crystalluria in a patients with the acquired immunodeficiency syndrome: a reminder. Am J Med 1988; 84: 791–792
- Salter A J. Trimethoprim-sulfamethoxazole: an assessment of more than 12 years of use. Clin Infect Dis 1982; 4: 197–236
- Kucers A, Bennett N. Trimethoprim, co-trimoxazole (Co-t), and other trimethoprim combinations. The Use of Antibiotics, 4th ed. JB Lippincott, Philadelphia 1987; 1118–1202
- Masur H. Prevention and treatment of pneumocystis pneumonia. N Engl J Med 1992; 327: 1853–1860
- Gurwith M J, Brunton J L, Lank B A. A prospective controlled investigation of prophylactic trimethoprim/sulfamethoxazole in hospitalized granulocytopenic patients. Am J Med 1979; 66: 248–256
- Dekker A W, Rozenberg-Arsaka M, Sixma J J, Verhoef J. Prevention of infection by trimethoprim/sulfamethoxazole plus ampho-tericin B in patients with acute non-lymphocytic leukemia. Ann Intern Med 1981; 95: 555–559
- Kaufman C A, Liepman M K, Bergman A G, Mioduszewski J. Trimethoprim/sulfamethaxazole prophylaxis in neutropenic patients. Am J Med 1983; 74: 599–607
- Gualiteri R J, Donowitz G R, Kaiser D L. Double-blind study of prophylactic trimethoprim/sulfamethoxazole in granulocytopenic patients with hematologic malignacies. Am J Med 1983; 74: 934–940
- Wt Hughes, Armstrong D, Bodey G P. Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. J Infect Dis 1990; 161: 381–396
- Ward T T, Thomas R G, Fye C L. Trimethoprim-sulfamethoxazole prophylaxis in granulocytopenic patients with leukemia: evaluation of serum antibiotic levels in a randomized, double-blind, placebo-controlled Department of Veteran Affairs study. Clin Infect Dis 1993; 17: 323–332
- Hughes W T. Prevention of infections in patients with T cell defects. Clin Infect Dis 1993; 17: S368–S371, Suppl 2
- Bozzette S A, Finklestein D M, Spector S A. A randomized trial of three antipneumocystis agents in patients with advanced human immunodeficiency virus infection. N Engl J Med 1995; 332: 693–699
- Hirschtick R E, Glassroth J, Jordan M C. Bacterial pneumonia in persons infected with the human immunodeficiency virus. N Engl J Med 1995; 333: 845–851
- Carr A, Tindall B, Brew B J. Low dose trimethoprim-sulfamethoxazole prophylaxis for toxoplasmic encephalitis in patients with AIDS. Ann Intern Med 1992; 117: 106–111
- Absar N, Daneshvar H, Beall G. Desensitization to trimethoprim/ sulfamethoxazole in HIV-infected patients. J Allergy Clin Immunol 1994; 93: 1001–1005
- Sattler F R, Cowan R, Nielson D M. Trimethoprim-sulfamethoxazole compared with pentamidine for treatment of Pneumocysris carinii pneumonia in the acquired immunodeficiency syndrome: a prospective noncrossover study. Ann Intern Med 1988; 109: 280–287